Senhwa's Pidnarulex Receives US FDA Fast Track Designation for the Treatment of Solid Tumors with BRCA1/2, PALB2 and other HR Gene Mutations
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com